The rising incidence of various chronic conditions and diseases such as Parkinson’s disease, diabetes, and Alzheimer’s disease is pushing up the demand for stem cells and cord blood cells across the globe, on account of the fact that these therapies can help considerably in organ transplantation, tissue grafting, drug testing, and the development of regenerative medicine. This is subsequently pushing up the requirement for biobanks and biobanking solutions across the world.
Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/biobanking-market/report-sample
Due to the aforementioned factors, the demand for biobanks is growing rapidly across the world. This is driving the advancement of the global biobanking market. As a result, the valuation of the market is predicted to surge from $25.8 billion in 2018 to $36.8 billion by 2024. Furthermore, the market is predicted to progress at a CAGR of 6.2% between 2019 and 2024. Depending on offering, the market is divided into services, software, equipment, and consumables.
Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=biobanking-market
Hence, it can be said with full confidence that the demand for biobanks will surge all over the world in the coming years, primarily because of the rising incidence of chronic diseases, the soaring geriatric population, and the allocation of huge funds for the development of biobanks in healthcare facilities around the world.
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Biobanking Market Research Report: By Product & Services (Equipment, Consumables, and Services), Sample Type (Blood Products), Storage Type (Manual Storage), Application (Regenerative Medicine) and End-User (Hospitals, Others) – Global Forecast till 2023 Overview:However, the biobanking market is also getting muddled by a lot of ethical questions owing to which the expected rise could drop a little during the forecast period.The global biobanking market is expected to rise from its previous valuation of USD 950 million in 2017 with a 7.6% CAGR during the forecast period (2018-2023).
These samples impact researches such as genomics and personalized medicine sector.
Free Report Sample At:https://www.marketresearchfuture.com/sample_request/5967 Competitive Landscape:Influential companies to impact the biobanking market are Thermo Fisher Scientific Inc., Greiner Holding AG, Hamilton Company, VWR Corporation, Tecan Trading AG, Becton Dickinson and Company, Ltd, Qiagen N.V., Merck KGaA, Brooks Automation, Inc., Chart Industries, Inc., Promega Corporation, Panasonic Healthcare Holdings Co., and others.
MRFR enlists them for their strategic developments which can help the market in the expansion.In 2019, the inauguration of the Cancer Phenome-Biobanking System and Biomonitoring Program or the Biobank facility at the Philippine General Hospital marked the development in cancer research status of the nation.
Regional AnalysisThe Americas dominates the global biobanking market owing to the increasing prevalence of chronic diseases and presence of a well-developed healthcare sector within the region.
Moreover, the increasing healthcare expenditure and presence of key players within the regional boundaries provide a favorable background for the market growth.Europe is the second largest in the global biobanking market.
